Open access peer-reviewed chapter

Effects of Neoadjuvant Chemotherapy in High-Grade Non-Metastatic Osteosarcoma of Extremities

By Milan Samardziski, Vesna Janevska, Beti Zafirova-Ivanovska, Violeta Vasilevska and Slavica Kraleva

Submitted: December 4th 2010Reviewed: August 24th 2011Published: February 1st 2012

DOI: 10.5772/24318

Downloaded: 1919

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Milan Samardziski, Vesna Janevska, Beti Zafirova-Ivanovska, Violeta Vasilevska and Slavica Kraleva (February 1st 2012). Effects of Neoadjuvant Chemotherapy in High-Grade Non-Metastatic Osteosarcoma of Extremities, Neoadjuvant Chemotherapy - Current Applications in Clinical Practice, Oliver F. Bathe, IntechOpen, DOI: 10.5772/24318. Available from:

chapter statistics

1919total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Chemotherapy and Mechanisms of Resistance in Breast Cancer

By Andre Lima de Oliveira, Roberto Euzebio dos Santos and Fabio Francisco Oliveira Rodrigues

Related Book

First chapter

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care

By Alice Laschuk Herlinger, Klesia Pirola Madeira, Renata Dalmaschio Daltoé, Ian Victor Silva, Marco César Cunegundes Guimarães and Leticia Batista Azevedo Rangel

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us